• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • Our Technology
      • TIM
      • shRNA
      • shARC Platform
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us

Celyad Announces October and November 2019 Investor Conference Schedule

October 2, 2019 By Celyad

Mont-Saint-Guibert, Belgium – Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to participate at the following investor conferences in October and November 2019.


Conference details:

Investir Day 1st Edition
Date: Thursday, October 3, 2019
Presentation time:  12:45 p.m. CEDT
Location:  Paris, France

CF&B Communication European Large & Midcap Event 19th Edition
Date: October 14-15, 2019
Location: Paris, France 

Bryan, Garnier & Co European Healthcare Conference
Date: Wednesday, November 13, 2019
Location: Paris, France 

Finance Avenue 2019
Date: Saturday, November 16, 2019
Presentation Time: 12:55 p.m. CEDT
Location: Brussels, Belgium 

Jefferies 2019 London Healthcare Conference
Date: November 20 – 21, 2019
Location: London, United Kingdom

Download press release(s)
Communiqué de presse
Press Release

Filed Under: Corporate, Non-regulated

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use